Skip to content

Ketoconazole

Published: July 26, 2026Updated: August 24, 2026

Ketoconazole is an azole antifungal medication used to treat various fungal infections including skin conditions like athlete's foot, ringworm, and seborrheic dermatitis, as well as systemic fungal infections. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. Due to its potential for serious side effects including liver toxicity and drug interactions, it requires monitoring and is typically reserved for cases where other treatments have failed.

Quick summary

Azole antifungal for treating skin and systemic fungal infections, requiring liver monitoring due to potential toxicity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
D01AC08
RxNorm
6135
Generic
Ketoconazole
Class
atc-d01
Brands
T8 Keto Flush, Ketodan, Mal-A-Ket, Ketochlor, Keto-C, Malacetic, Nizoral, Mal-A-Ket Wipes, Recorlev, Suffusion, Kuric, Xolegel, Extina
Availability
rx
Pregnancy
C
Lactation
caution
Routes
topical, otic, oral
Forms
spray, solution, gel, cream, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity and require medical intervention
Chronic overdose: cumulative hepatotoxicity with prolonged use above recommended doses
Immediate actions
gastric lavage within 1-2 hours of ingestion, activated charcoal administration, supportive care, liver function monitoring
Antidote
no specific antidote available(treatment is supportive; early intervention improves outcomes)
Poison Control: 1-800-222-1222

Special Populations

9 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks, topical use may be safer

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use unless benefits outweigh risks, may affect fetal adrenal function

Monitor

regular fetal monitoring and fetal adrenal function

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

discontinue breastfeeding or avoid drug, ketoconazole passes into breast milk

Monitor

monitor infant for adverse effects

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

65 years and above
caution
FDA Category
N
Dose Adjustment

consider dose reduction, start at lower end of dosing range

Key Recommendations

use with caution due to increased sensitivity, monitor liver function closely

Monitor

regular liver function tests and renal function monitoring

Use with caution and monitor for adverse effects.

✗

pediatric_age

under 2 years
unsafe
FDA Category
C
Dose Adjustment

not recommended

Key Recommendations

avoid systemic use in children under 2 years, topical formulations may be used with caution

Monitor

close monitoring if used

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

2 to 12 years
caution
FDA Category
C
Dose Adjustment

adjust dose based on body weight

Key Recommendations

use only when benefits outweigh risks, topical formulations preferred

Monitor

monitor liver function and for adverse effects

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe renal impairment
caution
FDA Category
N
Dose Adjustment

dose reduction may be needed, monitor closely

Key Recommendations

use with caution, ketoconazole is not significantly renally excreted but metabolites may accumulate

Monitor

regular monitoring of renal function and drug levels if available

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

moderate to severe hepatic impairment
unsafe
FDA Category
C
Dose Adjustment

avoid or significantly reduce dose

Key Recommendations

contraindicated in severe hepatic impairment due to hepatotoxic potential, use with extreme caution in moderate impairment

Monitor

frequent liver function tests, monitor for signs of hepatotoxicity

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1981

Original FDA approval for oral ketoconazole

Drug classWHO
2023

Drug class

Value:Antifungal - Imidazole

ATC code J02AB02 for systemic antifungals

usageFDA
2023

Primary indications

Value:Treatment of systemic and topical fungal infections

Approved therapeutic uses including candidiasis, dermatophytosis, seborrheic dermatitis

mechanismFDA
2023

Mechanism of action

Value:Inhibits ergosterol synthesis by blocking lanosterol 14-alpha-demethylase

Primary pharmacological mechanism

Treats cutaneous fungal infections (tinea, pityriasis versicolor, seborrheic dermatitis), oral and esophageal candidiasis, and systemic fungal infections like blastomycosis and histoplasmosis when other antifungals are ineffective.

Inhibits fungal cytochrome P450 enzymes, blocking the synthesis of ergosterol—an essential component of fungal cell membranes—causing cell death.

Can cause severe hepatotoxicity; regular liver function monitoring required. Multiple drug interactions due to CYP450 inhibition. Oral form carries FDA black box warning for hepatotoxicity and QT prolongation. Topical formulation has minimal systemic absorption.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy